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Abstract: Three new amide alkaloids piperlongumamides A–C (1–3), together with 12 known ones (4–15), were isolated from the 
fruits of Piper longum. The structures of the new isolates were determined using spectroscopic data analyses. Cytotoxic activity of 
these amides against HL-60 (human leukemia), A-549 (human lung cancer), MCF-7 (human breast cancer), SMMC-7721  
(human liver cancer) and SW480 (human rectal cancer) cell lines were evaluated. Piperchabamide B (11) exhibited weak inhibitory 
activity against HL-60 (IC50 = 21.32 μM ), A-549 (IC50 = 23.82 μM ) and MCF-7 (IC50 = 16.58 μM ) cell lines. 
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Introduction 
Piper longum L. (Piperaceae) is a slender aromatic climber 
with perennial woody roots which grows primarily in tropical 
regions. Its fruits and roots are used to treat various disease 
and ailments in traditional Chinese medicinal and  
ethnomedicinal practice. Uses include expectorant, curing 
dyspepsia, sleep problems, asthma, nausea, diarrhea, lumbar-
leg pain and arthralgia.1 The plant mainly contains amide alka-
loids which have been used with anti-hepatitis B virus (anti-
HBV),2,3 apoptotic,4 leishmanicidal,5 cytotoxic,6 mosquito 
larvicidal,7,8 phytotoxic,9 anti-inflammatory,10 antihyper-
lipidemic,11,12 cell adhesion inhibitory,13 antiplatelet,11,14 acyl-
CoA: cholesterol acyltransferase (ACAT) inhibitory,15 anti-
fungal16 and coronary vasorelaxant activities.17 In addition to 
amide alkaloids, phytochemicals present also include prenylat-
ed phenolic compounds18 and aromatic esters19 are found in the 
plant. In our continuing research on bioactive constituents of 
Piper species,20–22 three new amide alkaloids piperlonguma-
mides A–C (1–3), along with 12 previously  
identified ones (Figure 1) were isolated from the fruits of P. 
longum. The structural elucidation of the new compounds and 
the bioassay results are reported. 
Results and Discussion 
The molecular formula of compound 1, C22H31NO, was  
determined using the HREIMS (m/z 325.2413 [M]+), indicating
eight degrees of unsaturation. Its IR spectrum showed strong 
absorption bands at 1722, 1636 and 1452 cm–1 implying the 
existence of unsaturated amide and aromatic functionalities. 
The 1H NMR and 13C NMR spectra of 1 (Table 1) showed 
signals for one monosubstituted benzene ring [δH 7.27 (2H, m) 
and 7.17 (3H, m)], two conjugated trans double bonds [δH 7.30 
(dd, J = 14.8, 10.8 Hz), 6.24 (d, J = 14.8 Hz), 6.17 (dd, J = 
15.2, 10.8 Hz) and 6.08 (dt, J = 15.2, 7.0 Hz)], one carbonyl 
group (δC 166.0) and several methylene groups. Moreover, 
amide alkaloids are major constituents of Piper plants, and the 
compound might be a phenylalkenoyl derivative. A piperidine 
ring was determined by the 1H-1H COSY spectrum (Figure 2). 
The length of the alkenoyl group was determined as 11 carbon 
atoms according to the molecular formula of compound 1. 
Finally, on the basis of the HMBC correlations (Figure 2) from 
H-3 to C-1, H2-1″ and H2-5″ to C-1, H2-10 to C-1′ and H2-11 
to C-2′ and C-6′, the structure of 1 was determined to be 
(2E,4E)-N-(11-phenylundecadienoyl)piperidine and was given 
the common name piperlongumamide A. 
The molecular formula of compound 2, C22H33NO, was  
determined by HREIMS at m/z 327.2554 [M]+. Its IR spectrum 
showed absorption bands at 1723, 1657, 1618 and 1439 cm–1 
indicating the existence of unsaturated amide and aromatic 
groups. Comparison of the MS and NMR data of 2 with those 
of 1 (Table 1), the difference was that a trans double bond at 
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C-4(5) disappeared in compound 2. Based on the 1H-1H COSY 
and HMBC correlations of 2 (Figure 2), the structure of 2 was 
deduced to be (2E)-N-(11-phenylundecenoyl)piperidine and 
was given the common name piperlongumamide B. 
Compound 3 has the molecular formula C19H31NO based on 
HREIMS at m/z 289.2414 [M]+. The IR spectrum indicated the 
presence of an unsaturated amide group (1720, 1713, 1630 and 
1447 cm–1). The 1H and 13C NMR spectra of 3 (Table 2)  
displayed signals for two trans-conjugated diene moiety [δH 
6.24 (1H, d, J = 15.0 Hz, H-2), 7.29 (1H, dd, J = 15.0, 11.0 Hz, 
H-3), 6.18 (1H, dd, J = 15.0, 11.0 Hz, H-4) and 6.08 (1H, dt, J 
= 15.0, 7.2 Hz, H-5)], one methyl group [δH 0.89 (3H, t, J = 
6.8 Hz, H-14)], one carbonyl group (δH 166.1) and several 
methylene groups. Also, signals at δH 5.32 (1H, m, H-9) and 
5.38 (1H, m, H-10) were due to an additional double bond, 
which was deduced as Z configuration by the chemical shifts 
of the allylic carbons [δC 26.8 (C-8) and 27.1 (C-11)].21,22 
Based on above analysis and by comparison of its NMR data 
with those of compound 1, compound 3 was deduced as an 
alkenoyl piperidine. According to 1H-1H COSY correlations of 
3 (Figure 2), the connections from C-1 to C-11, C-13 to C-14 
and C-1′ to C-5′ were confirmed. Finally, based on the HMBC 
 
Figure 1.  Structures of amide alkaloids 1–15 from Piper longum 
 
Figure 2.  Key 1H-1H COSY (bold) and HMBC (arrows, H→C) 
correlations of compounds 1–3 
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correlations (Figure 2) from H-3, H2-1′ and H2-5′ to C-1, H-10 
to C-12, Me-14 to C-12 and C-13, the structure of 3 was  
determined to be (2E,4E,9Z)-N-tetradecatrienoylpiperidine and 
was given the common name piperlongumamide C. 
The known compounds were identified as piperine (4),23 
isopiperine (5),24 chavicine (6),24 piperlonguminine (7),25  
pellitorine (8),26 brachystamide B (9),27 guineensine (10),25 
piperchabamide B (11),28 (2E,4E)-N-dodecadienoylpiperidine 
(12),29 dehydropipernonaline (13),12 pipernonaline (14)16 and 
piperolein B (15)12 by comparison of their NMR and MS data 
with those reported in the literature. 
In a previous study, we found that an amide alkaloid 1-
[(9E)-10-(3,4-methylenedioxyphenyl)-9-decenoyl]pyrrolidine 
from P. boehmeriaefolium was cytotoxic.21 Therefore, all of 
the amides from P. longum were evaluated for their inhibitory 
activities against HL-60 (human leukemia), A-549 (human 
lung cancer), MCF-7 (human breast cancer), SMMC-7721 
(human liver cancer) and SW480 (human rectal cancer) cell 
lines. Piperchabamide B (11) exhibited weak inhibitory activity
against HL-60 cell line (IC50 = 21.32 μM), A-549 (IC50 = 
23.82 μM) and MCF-7 (IC50 = 16.58 μM) (Table 3). Other 
tested compounds were inactive. 
 
Experimental Section 
General Experimental Procedures. UV spectra were  
recorded on a Shimadzu double-beam 210A spectrometer 
(Shimadzu Co., Shimadzu, Japan). IR spectra were recorded 
on a Bruker Tensor 27 Fourier transform infrared spectrometer 
(Bruker, Karlsruhe, Germany) with KBr pellets. ESIMS and 
HREIMS analyses were carried out on an API Qstar-Pulsar-1 
mass spectrometer (Applied Biosystems/MDS Sciex, Ontario, 
Canada) and Waters AutoSpec Premier P776 (Waters, Milford, 
USA), respectively. 1H and 13C NMR spectra were collected 
on a Bruker AM-400, DRX-500 and Avance III-600 spec-
trometers (Bruker Bio-Spin GmbH, Rheinstetten, Germany) 
with TMS as an internal standard. Semi-preparative HPLC 
was performed on an Agilent 1200 series pump (Agilent 
Technologies, Santa Clara, USA) equipped with a diode array 
detector and a Zorbax SB-C18 column (5.0 μm,  9.4 × 250 
mm). Both analytical and preparative TLC conductedusing 
silica gel plates (GF254, Yantai Institute of Chemical 
Technology, Yantai, China). The spots were initially visualized
using UV light (254 and 366 nm) and subsequently visualised 
by spraying a solution of 5% H2SO4 onto the TLC plate, which 
was subsequently heated. Column chromatography was  
performed using silica gel (80–100 mesh and 300–400 mesh; 
Qingdao Makall Group Co., Ltd., Qingdao, China), C18 silica 
gel (40–75 μm, Fuji Silysia Chemical, Ltd., Kasugai, Japan) 
and Sephadex LH-20 (GE Healthcare Bio-Xciences AB,  
Uppsala, Sweden). 
 
Plant Material. The fruits of P. longum were purchased 
from Yikan Chinese Herbal Medicine Ltd., Qujing, China, in 
October 2011. The plant material was identified by Dr.  
Guang-Wan Hu, at Kunming Institute of Botany, Chinese 
Academy of Sciences. A voucher specimen (QJ1101) has been 
deposited at Key Laboratory of Economic Plants and  
Biotechnology, Kunming Institute of Botany. 
 
Table 2. 1H (600 MHz) and 13C NMR (150 MHz) spectral data 
of 3 in CDCl3 (δ in ppm) 
No. δC δH 
1 166.1 C  
2 117.8 CH 6.24, 1H, d (15.0)
3 144.1 CH 7.29, 1H, dd (15.0, 11.0) 
4 129.1 CH 6.18, 1H, dd (15.0, 11.0) 
5 143.4 CH 6.08, 1H, dt (15.0, 7.2) 
6 32.6 CH2 2.16, 2H, q like (7.2) 
7 28.9 CH2 1.48, 2H, m 
8 26.8 CH2 2.04, 2H, m 
9 129.1 CH 5.32, 1H, m 
10 130.7 CH 5.38, 1H, m 
11 27.1 CH2 2.01, 2H, m 
12 32.0 CH2 1.31, 2H, m 
13 22.5 CH2 1.31, 2H, m  
14 14.2 CH3 0.89, 3H, t (6.8) 
1′ 45.2a CH2 3.56, 2H, m 
2′ 26.3 CH2  1.58, 2H, m 
3′ 24.7 CH2 1.66, 2H, m 
4′ 26.3 CH2  1.58, 2H, m 
5′ 45.2a CH2  3.56, 2H, m 
aDetected by HSQC spectrum. 




δC (150 MHz) δH (600 MHz) δC (100 MHz) δH (400 MHz) 
1 166.0 C  165.8 C  
2 118.0 CH 6.24, 1H, d (14.8) 120.2 CH 6.23, 1H, br. d (15.1) 
3 143.7 CH 7.30,1H, dd (14.8, 10.8) 146.6 CH 6.84,1H, dt (15.1, 7.0)
4 128.9 CH 6.17, 1H, dd (15.2, 10.8) 32.7 CH2 2.18, 2H, q like (7.0) 
5 143.3 CH 6.08, 1H, dt (15.2, 7.0) 28.5 CH2 1.43, 2H, m 
6 33.1 CH2 2.14, 2H, q like (7.0) 29.5b CH2 1.29, 2H, m 
7 28.8 CH2 1.41, 2H, m 29.5b CH2 1.29, 2H, m 
8 29.2 CH2 1.32, 2H, m 29.4b CH2 1.29, 2H, m 
9 29.2 CH2 1.32, 2H, m 29.3b CH2 1.29, 2H, m 
10 31.6 CH2 1.60, 2H, m 31.6 CH2 1.60, 2H, m 
11 36.0 CH2 2.59, 2H, t (7.8) 36.1 CH2 2.59, 2H, t (7.7) 
1′ 142.9 C  143.0 C  
2′,6′ 128.4 CH 7.27, 2H, m 128.3 CH  7.27, 2H, m 
3′,5′ 128.5 CH  7.17, 2H, m 128.5 CH  7.18, 2H, m 
4′ 125.7 CH 7.17, 1H, m 125.7 CH 7.18, 1H, m 
1″ 45.2a CH2 3.57, 2H, m 42.9a CH2 3.54, 2H, m 
2″ 26.3 CH2 1.58, 2H, m 26.2 CH2 1.56, 2H, m 
3″ 24.7 CH2 1.65, 2H, m  24.8 CH2 1.65, 2H, m  
4″ 26.3 CH2 1.58, 2H, m 26.2 CH2 1.56, 2H, m 
5″ 45.2a CH2 3.56, 2H, m 46.9a CH2 3.54, 2H, m 
aDetected by HSQC spectrum. bData under the same entry are exchangeable. 
280      J. YANG et al.                                                                                                                         Nat. Prod. Bioprospect. 2013, 3, 277–281 
 
         
Extraction and Isolation. The dried powdered fruits (20 kg) 
of P. longum were extracted using MeOH (4, 3 and 3 h, resp.) 
under reflux. The combined MeOH extracts were evaporated 
under reduced pressure to yield a residue, which was suspended
in H2O and then partitioned successively with petroleum ether 
and CHCl3 to produce two corresponding portions. After TLC 
testing, the two portions were combined as both contained 
alkaloids. The combined extract (1377 g) was subjected to 
column chromatography over silica gel G (80–100 mesh)  
using petroleum ether/EtOAc (1׃0→0׃1) to yield ten fractions 
(Fr. A–J) and also compound 4 (1.8 g). 
Fr. D (19 g) was separated using column chromatography 
(C18, MeOH/H2O, 80׃20) to give 8 (56.2 mg). Fr. E (12 g) 
was partitioned by column chromatography (C18, MeOH/H2O, 
60׃40→95׃5) to produce fractions (E1–E7). Fr. E1 (1.1 g) was 
fractionated by column chromatography (Sephadex LH-20, 
MeOH; silica gel, petroleum ether/Me2CO, 1׃1) and prep. 
TLC (petroleum ether/EtOAc, 10׃1) to give 5 (20.0 mg), 6 
(27.0 mg) and 7 (8.2 mg). 
Fr. E3 (2.5 g) was fractionated by column chromatography 
(Sephadex LH-20, MeOH; silica gel, petroleum ether/Me2CO, 
3׃1) and semi-preparative HPLC (MeOH/Me3CN/H2O, 
50׃35׃15, 4 mL/min) to obtain 13 (23.8 mg, tR = 5.995 min) 
and 14 (37.3 mg, tR = 6.818 min). Fr. E4 was fractionated by  
column chromatography (Sephadex LH-20, MeOH) to give 
two parts (E4a and E4b). Fr. E4a (233.6 mg) was subjected to 
by column chromatography (silica gel, petroleum ether/Et2NH, 
50׃1) and semi-preparative HPLC (MeCN/H2O, 90׃10, 3 
ml/min) to give 12 (1 mg, tR = 11.984 min), 1 (2.1 mg, tR = 
12.858 min), 2 (4 mg, tR = 16.182 min), 3 (8.4 mg, tR = 13.959 
min). Fr. E4b (743.7 mg) was isolated repeatedly by column 
chromatography (silica gel, petroleum ether/Me2CO, 5׃1;  
petroleum ether/EtOAc, 4׃1; petroleum ether/Et2NH, 10׃1) to 
give 10 (17.2 mg) and 11 (18.0 mg), and a remaining fraction, 
which was purified by semi-preparative HPLC (MeCN/H2O, 
60׃40, 4 mL/min) to give 15 (3.5 mg, tR = 17.027 min) and 11 
(4 mg, tR = 28.529 min). Fr. E5 (1.3 g) was fractionated by 
column chromatography (Sephadex LH-20, MeOH) and prep. 
TLC (CHCl3/EtOAc, 10׃1) to give 9 (23.9 mg). 
 
Piperlongumamide A (1): pale yellow oil; UV (MeOH):  
λmax (log ε) 205 (2.77) nm. IR (KBr) νmax 1722, 1636, 1452, 
1254, 748, 699, 571 cm–1. 1H and 13C NMR spectral data see 
Table 1. ESIMS (positive) m/z 326 [M + H]+; HREIMS: m/z 
325.2413 [M]+ (calcd for C22H31NO, 325.2406). 
 
Piperlongumamide B (2): pale yellow oil; UV (MeOH):  
λmax (log ε) 209 (2.93) nm. IR (KBr) νmax 1723, 1657, 1618, 
1439, 1219, 1069, 1023, 974, 903, 637 cm–1. 1H and 13C NMR 
spectral data see Table 1. ESIMS (positive) m/z 350 [M + Na]+; 
HREIMS: m/z 327.2554 [M]+ (calcd for C22H33NO, 327.2562). 
Piperlongumamide C (3): pale yellow oil; UV (MeOH):  
λmax (log ε) 207 (2.33) nm. IR (KBr) νmax 1720, 1713, 1630, 
1447, 1253, 1229, 1166, 1082, 1022, 978, 800, 588 cm–1. 1H 
and 13C NMR spectral data see Table 2. ESIMS (positive) m/z 
290 [M + H]+; HREIMS: m/z 289.2414 [M]+ (calcd for 
C19H31NO, 289.2406). 
 
MTS Assay for Cytotoxicity. The isolated amide alkaloids 
were tested in vitro for their cytotoxicity against proliferation 
of human leukemia HL-60 cell line, human lung cancer A-549, 
human breast cancer MCF-7, human liver cancer SMMC-7721 
and human rectal cancer SW480 using the MTS assay. 
The 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxy-
phenyl)-2-(4-sulfopheny)-2H-tetrazolium (MTS) (Promega, 
Beijing, China) is a mix-based cell titer assay and was  
performed as previous described.30 Initially, cells in their  
log-phase of their cycle were seeded in 96-well plates (5000–
10000 cells/well, NEST Biotechnology, Wuxi, China) using a 
standard 100 μL volume, with paired single cell suspension 
containing 10% fetal bovine serum (DMEM or RMPI1640, 
Thermo Fisher Scientific, Beijing, China). The cell were  
further treated with indicated concentrations of the compounds 
dissolved in DMSO, which were set the regular thickness  
40 μM for the initial screening and five concentrations of each 
compound were fixed in the concentration compounds inhibited
tumor cell growth by approximately 50% to achieve a total 
culture medium in a volume of 200 μL. After incubation for  
48 h at 37 °C, a 20 μL of MTS solution and 100 μL DMEM 
were added into the well, incubation was continued for another  
1–4 h. The absorbance was measured at the detection wave-
length of 490 nm (L1) and the reference wavelength of 680 nm 
(L2)31 and cytotoxicity for each compound was expressed as 
IC50 values. 
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HL-60 SMMC-7721 A-549 MCF-7 SW480 
Piperchabamide B (11) 21.32 > 40 23.82 16.58 > 40 
Cisplatin (positive control) 1.32 6.24 11.83 15.17 12.95 
Taxol (positive control) < 0.008 < 0.008 < 0.008 < 0.008 < 0.008 
*Other tested compounds were inactive. 
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